Skip to main content

Checkpoint Therapeutics, Inc.

CKPTDelisted May 30, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001651407

Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Checkpoint Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CKPT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders7068−2
Shares11.0M10.6M−430.5K (−3.9%)
Value$32.5M$34.9M+$2.43M (+7.5%)

New holders (14)

Institutions that held Checkpoint Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CKPT in Q3 2021
InstitutionSharesValue% of portfolio
Kepos Capital LP100,000$330.0K0.02%
Telemetry Investments, L.L.C.70,000$231.0K0.32%
Exane Derivatives48,230$159.2K0.04%
Capstone Investment Advisors, LLC17,636$58.0K0.00%
Virtu Financial LLC16,723$55.0K0.00%
Walleye Capital LLC16,530$55.0K0.00%
Nomura Holdings Inc16,100$53.0K0.00%
Segall Bryant & Hamill, LLC15,000$50.0K0.00%
Occudo Quantitative Strategies LP13,234$44.0K0.01%
Cordant, Inc.10,820$36.0K0.02%
Total Clarity Wealth Management, Inc.2,500$8.00K0.00%
Tower Research Capital LLC (TRC)1,746$6.00K0.00%
Northwestern Mutual Wealth Management Co500$2.00K0.00%
Group One Trading, L.P.100$00.00%

Sold out (16)

Institutions that held Checkpoint Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.